Elicio Therapeutics, Inc
(NASDAQ: ELTX)
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
7.940
-0.385
(-4.62%)
Range
7.930 - 8.445
(6.49%)
Open
8.360
Previous Close
8.325
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
31,254
Value
-
Remark
Delayed prices. Updated at 06 Dec 2025 00:06.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
